Lee's Pharmaceutical Holdings Limited
HKEX:0950.HK
1.28 (HKD) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,053.034 | 1,233.148 | 1,266.157 | 1,216.716 | 1,218.913 | 1,137.626 | 1,008.522 | 929.821 | 922.15 | 955.208 | 696.953 | 534.333 | 399.685 | 255.81 | 173.837 | 125.421 | 76.712 | 43.531 | 38.528 | 30.395 | 18.498 | 11.644 | 10.346 |
| Cost of Revenue
| 501.723 | 462.393 | 459.873 | 435.65 | 420.657 | 391.255 | 326.118 | 261.586 | 273.986 | 284.685 | 193.7 | 153.498 | 107.852 | 77.32 | 49.262 | 36.779 | 25.719 | 16.86 | 13.216 | 10.381 | 5.134 | 3.2 | 2.466 |
| Gross Profit
| 551.311 | 770.755 | 806.284 | 781.066 | 798.256 | 746.371 | 682.404 | 668.235 | 648.164 | 670.523 | 503.253 | 380.835 | 291.833 | 178.49 | 124.575 | 88.642 | 50.993 | 26.671 | 25.312 | 20.014 | 13.364 | 8.444 | 7.88 |
| Gross Profit Ratio
| 0.524 | 0.625 | 0.637 | 0.642 | 0.655 | 0.656 | 0.677 | 0.719 | 0.703 | 0.702 | 0.722 | 0.713 | 0.73 | 0.698 | 0.717 | 0.707 | 0.665 | 0.613 | 0.657 | 0.658 | 0.722 | 0.725 | 0.762 |
| Reseach & Development Expenses
| 96.804 | 168.885 | 243.835 | 203.294 | 149.945 | 153.171 | 85.057 | 67.886 | 47.075 | 37.964 | 32.262 | 16.304 | 11.835 | 5.59 | 5.686 | 2.101 | 1.499 | 1.113 | 0.878 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 188.612 | 198.413 | 297.265 | 237.721 | 239.088 | 188.926 | 159.218 | 146.511 | 112.31 | 99.345 | 78.511 | 63.042 | 37.09 | 29.299 | 22.486 | 19.954 | 14.192 | 14.737 | 11.035 | 10.173 | 12.054 | 8.415 | 5.232 |
| Selling & Marketing Expenses
| 304.296 | 346.467 | 366.439 | 279.947 | 251.759 | 221.74 | 214.15 | 204.225 | 256.465 | 309.202 | 222.85 | 179.512 | 156.437 | 79.193 | 47.842 | 36.983 | 22.597 | 14.42 | 14.614 | 13.207 | 6.85 | 5.03 | 5.383 |
| SG&A
| 494.188 | 544.88 | 663.704 | 517.668 | 490.847 | 410.666 | 373.368 | 350.736 | 368.775 | 408.547 | 301.361 | 242.554 | 193.527 | 108.492 | 70.328 | 56.937 | 36.789 | 29.157 | 25.649 | 23.38 | 18.904 | 13.445 | 10.615 |
| Other Expenses
| 0 | -19.276 | -18.156 | -29.778 | -29.491 | -14.172 | 2.984 | 1.741 | 0.713 | 3.582 | 4.458 | 4.485 | -5.491 | -5.372 | -4.832 | -1.246 | -0.746 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 590.992 | 694.489 | 889.383 | 691.184 | 611.301 | 549.665 | 434.304 | 350.862 | 409.234 | 437.797 | 330.695 | 252.939 | 199.871 | 108.71 | 71.182 | 57.792 | 37.542 | 30.27 | 26.527 | 23.38 | 18.904 | 13.445 | 10.615 |
| Operating Income
| 36.042 | 123.019 | -0.694 | 151.923 | 244.596 | 466.936 | 276.828 | 298.426 | 286.425 | 231.492 | 180.361 | 134.362 | 98.793 | 70.178 | 53.472 | 31.086 | 13.678 | -2.677 | 0.555 | -2.743 | -4.826 | -4.785 | -1.998 |
| Operating Income Ratio
| 0.034 | 0.1 | -0.001 | 0.125 | 0.201 | 0.41 | 0.274 | 0.321 | 0.311 | 0.242 | 0.259 | 0.251 | 0.247 | 0.274 | 0.308 | 0.248 | 0.178 | -0.061 | 0.014 | -0.09 | -0.261 | -0.411 | -0.193 |
| Total Other Income Expenses Net
| -5.257 | -8.699 | -9.217 | -17.886 | -18.519 | 261.491 | 18.901 | -12.741 | 6.1 | -8.155 | -0.926 | 1.035 | -1.041 | -2.217 | -0.689 | -0.505 | -0.89 | -0.704 | 1.324 | 0.058 | -0.593 | -0.596 | 0.681 |
| Income Before Tax
| 30.785 | 67.861 | 1,969.366 | 134.037 | 122.886 | 446.384 | 257.628 | 282.604 | 253.935 | 228.153 | 176.09 | 133.17 | 97.752 | 67.961 | 52.783 | 30.581 | 12.788 | -3.381 | 0.109 | -3.308 | -5.419 | -5.381 | -1.317 |
| Income Before Tax Ratio
| 0.029 | 0.055 | 1.555 | 0.11 | 0.101 | 0.392 | 0.255 | 0.304 | 0.275 | 0.239 | 0.253 | 0.249 | 0.245 | 0.266 | 0.304 | 0.244 | 0.167 | -0.078 | 0.003 | -0.109 | -0.293 | -0.462 | -0.127 |
| Income Tax Expense
| 10.836 | 22.026 | 9.482 | 55.503 | 59.541 | 56.621 | 54.689 | 50.198 | 40.938 | 41.368 | 27.087 | 20.104 | 13.728 | 10.039 | 6.414 | 2.521 | 1.418 | 0.088 | -0.044 | -0.04 | -0.056 | -1.534 | -1.418 |
| Net Income
| 16.698 | 51.284 | 1,987.176 | 78.534 | 63.345 | 418.269 | 232.559 | 252.002 | 229.052 | 192.83 | 150.467 | 113.807 | 83.906 | 58.026 | 46.369 | 28.06 | 11.37 | -3.469 | 0.153 | -3.268 | -5.363 | -3.467 | -1.317 |
| Net Income Ratio
| 0.016 | 0.042 | 1.569 | 0.065 | 0.052 | 0.368 | 0.231 | 0.271 | 0.248 | 0.202 | 0.216 | 0.213 | 0.21 | 0.227 | 0.267 | 0.224 | 0.148 | -0.08 | 0.004 | -0.108 | -0.29 | -0.298 | -0.127 |
| EPS
| 0.028 | 0.087 | 3.38 | 0.13 | 0.11 | 0.71 | 0.39 | 0.43 | 0.4 | 0.36 | 0.28 | 0.23 | 0.18 | 0.13 | 0.11 | 0.068 | 0.031 | -0.01 | 0 | -0.011 | -0.019 | -0.014 | -0.007 |
| EPS Diluted
| 0.028 | 0.087 | 3.37 | 0.13 | 0.11 | 0.7 | 0.39 | 0.43 | 0.39 | 0.34 | 0.27 | 0.22 | 0.18 | 0.12 | 0.11 | 0.067 | 0.031 | -0.01 | 0 | -0.011 | -0.019 | -0.014 | -0.007 |
| EBITDA
| 109.82 | 229.059 | 2,125.45 | 279.427 | 235.547 | 516.171 | 319.992 | 332.135 | 301.046 | 259.711 | 194.446 | 148.719 | 109.733 | 76.419 | 58.574 | 34.436 | 16.404 | -0.294 | 0.836 | -1.335 | -3.492 | -3.049 | -1.276 |
| EBITDA Ratio
| 0.104 | 0.223 | 0.115 | 0.231 | 0.278 | 0.456 | 0.314 | 0.386 | 0.281 | 0.28 | 0.279 | 0.278 | 0.258 | 0.298 | 0.337 | 0.274 | 0.212 | -0.028 | 0.022 | -0.044 | -0.189 | -0.262 | -0.123 |